Factors such as developments in molecular imaging technologies, growing consumer interest for non-invasive small-animal imaging approaches, and growing R&D investments to support preclinical research are slated to propel market growth.

The global preclinical imaging anticipated to have held a market value of USD 2.01 billion in the year 2017 and is expected to grow at a CAGR of 6.3% during the forecast period.

Preclinical Imaging (IN-VIVO) Market projected to grow at a CAGR of 6.3% over the forecast period 2018 – 2023